View in EDS PDF Full Text

AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.

Saved in:
Bibliographic Details
Title: AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.
Authors: Rabe KF; LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf, Germany.; Christian-Albrechts University of Kiel, Airway Research Center North, Kiel, Germany.; German Center for Lung Research, Grosshansdorf, Germany., Martinez FJ; Weill Cornell Medical College, New York, NY, USA., Bhatt SP; University of Alabama at Birmingham, Birmingham, AL, USA., Kawayama T; Kurume University School of Medicine, Fukuoka, Japan., Cosio BG; Hospital Universitario Son Espases-IdISBa-CIBERES, Palma de Mallorca, Spain., Mroz RM; Medical University of Bialystok, Bialystok, Poland., Boomsma MM; Sanofi, Amsterdam, Netherlands., Goulaouic H; Sanofi, Chilly-Mazarin, France., Nivens MC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Djandji M; Sanofi, Cambridge, MA, USA., Soler X; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Liu Y; Sanofi, Bridgewater, NJ, USA., Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Xu CR; Sanofi, Bridgewater, NJ, USA., Amin N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Staudinger H; Sanofi, Bridgewater, NJ, USA., Lederer DJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Abdulai RM; Former Sanofi employee.
Source: ERJ open research [ERJ Open Res] 2024 Sep 23; Vol. 10 (5). Date of Electronic Publication: 2024 Sep 23 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39319046
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rabe+KF%22">Rabe KF</searchLink>; LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf, Germany.; Christian-Albrechts University of Kiel, Airway Research Center North, Kiel, Germany.; German Center for Lung Research, Grosshansdorf, Germany.<br /><searchLink fieldCode="AU" term="%22Martinez+FJ%22">Martinez FJ</searchLink>; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bhatt+SP%22">Bhatt SP</searchLink>; University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Kawayama+T%22">Kawayama T</searchLink>; Kurume University School of Medicine, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Cosio+BG%22">Cosio BG</searchLink>; Hospital Universitario Son Espases-IdISBa-CIBERES, Palma de Mallorca, Spain.<br /><searchLink fieldCode="AU" term="%22Mroz+RM%22">Mroz RM</searchLink>; Medical University of Bialystok, Bialystok, Poland.<br /><searchLink fieldCode="AU" term="%22Boomsma+MM%22">Boomsma MM</searchLink>; Sanofi, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Goulaouic+H%22">Goulaouic H</searchLink>; Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Nivens+MC%22">Nivens MC</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Djandji+M%22">Djandji M</searchLink>; Sanofi, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Soler+X%22">Soler X</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Sanofi, Bridgewater, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Kosloski+MP%22">Kosloski MP</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Xu+CR%22">Xu CR</searchLink>; Sanofi, Bridgewater, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Amin+N%22">Amin N</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Staudinger+H%22">Staudinger H</searchLink>; Sanofi, Bridgewater, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lederer+DJ%22">Lederer DJ</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Abdulai+RM%22">Abdulai RM</searchLink>; Former Sanofi employee.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101671641%22">ERJ open research</searchLink> [ERJ Open Res] 2024 Sep 23; Vol. 10 (5). <i>Date of Electronic Publication: </i>2024 Sep 23 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Respiratory+Society%22">European Respiratory Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101671641 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2312-0541 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223120541%22">23120541 </searchLink><i>NLM ISO Abbreviation: </i>ERJ Open Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39319046
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1183/23120541.00718-2023
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rabe KF
      – PersonEntity:
          Name:
            NameFull: Martinez FJ
      – PersonEntity:
          Name:
            NameFull: Bhatt SP
      – PersonEntity:
          Name:
            NameFull: Kawayama T
      – PersonEntity:
          Name:
            NameFull: Cosio BG
      – PersonEntity:
          Name:
            NameFull: Mroz RM
      – PersonEntity:
          Name:
            NameFull: Boomsma MM
      – PersonEntity:
          Name:
            NameFull: Goulaouic H
      – PersonEntity:
          Name:
            NameFull: Nivens MC
      – PersonEntity:
          Name:
            NameFull: Djandji M
      – PersonEntity:
          Name:
            NameFull: Soler X
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Kosloski MP
      – PersonEntity:
          Name:
            NameFull: Xu CR
      – PersonEntity:
          Name:
            NameFull: Amin N
      – PersonEntity:
          Name:
            NameFull: Staudinger H
      – PersonEntity:
          Name:
            NameFull: Lederer DJ
      – PersonEntity:
          Name:
            NameFull: Abdulai RM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 09
              Text: 2024 Sep 23
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2312-0541
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: ERJ open research
              Type: main
ResultId 1